<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Blog Hub &#187; NAT</title>
	<atom:link href="http://www.stockbloghub.com/tag/nat/feed" rel="self" type="application/rss+xml" />
	<link>http://www.stockbloghub.com</link>
	<description>Start Your Investing Research Here!</description>
	<lastBuildDate>Wed, 23 May 2012 20:22:08 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>(GPRO) Gen-Probe Files Pre-market Approval Application for Prostate Cancer Test</title>
		<link>http://www.stockbloghub.com/2010/09/26/gpro-gen-probe-files-pre-market-approval-application-for-prostate-cancer-test/52758</link>
		<comments>http://www.stockbloghub.com/2010/09/26/gpro-gen-probe-files-pre-market-approval-application-for-prostate-cancer-test/52758#comments</comments>
		<pubDate>Mon, 27 Sep 2010 05:04:47 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Research Services]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[Abbott Laboratories]]></category>
		<category><![CDATA[ABT]]></category>
		<category><![CDATA[Affiliated Computer Services Inc]]></category>
		<category><![CDATA[BDX]]></category>
		<category><![CDATA[Becton Dickinson Company]]></category>
		<category><![CDATA[Gen-Probe Inc.]]></category>
		<category><![CDATA[GPRO]]></category>
		<category><![CDATA[NAT]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=52758</guid>
		<description><![CDATA[Diagnostic products maker Gen-Probe Inc. (GPRO) has submitted a Pre-market Approval (PMA) application to the U.S. Food and Drug Administration (FDA) for its PROGENSA PCA3 assay, a novel molecular test designed to aid the diagnosis of prostate cancer. Gen-Probe is seeking FDA approval to use the assay to test urine specimens from men who earlier had a negative prostate biopsy. This represents the second of the four PMA submissions that Gen-Probe plans to complete in 2010. The FDA has formally accepted the PROGENSA PMA and has advised Gen-Probe that a meeting (timeline unspecified) of the Medical Devices Advisory Committee&#8217;s Immunology Panel will be necessary to support approval of the filling. Gen-Probe acquired the exclusive global rights to the PCA3 (a genetic marker for prostate cancer) from Canadian cancer diagnostic tests ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/09/26/gpro-gen-probe-files-pre-market-approval-application-for-prostate-cancer-test/52758/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(GPRO) Gen-Probe&#8217;s Earnings Report Leaps Ahead of Forecast</title>
		<link>http://www.stockbloghub.com/2010/07/31/gpro-gen-probes-earnings-report-leaps-ahead-of-forecast/45488</link>
		<comments>http://www.stockbloghub.com/2010/07/31/gpro-gen-probes-earnings-report-leaps-ahead-of-forecast/45488#comments</comments>
		<pubDate>Sat, 31 Jul 2010 16:17:54 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Research Services]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[Abbott Laboratories]]></category>
		<category><![CDATA[ABT]]></category>
		<category><![CDATA[Gen-Probe Inc.]]></category>
		<category><![CDATA[GPRO]]></category>
		<category><![CDATA[NAT]]></category>
		<category><![CDATA[Nordic American Tanker Shipping Limited]]></category>
		<category><![CDATA[Novartis AG]]></category>
		<category><![CDATA[NVS]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=45488</guid>
		<description><![CDATA[Diagnostic product maker Gen-Probe Inc. (GPRO) announced second-quarter fiscal 2010 adjusted earnings of 52 cents per share, exceeding the Zacks Consensus Estimate of 49 cents and the year-ago earnings of 45 cents. Net income soared 42% year-over-year to $28.1 million (or 57 cents a share), riding on solid top-line growth. Revenues Revenues surged 15% year over year to $138.6 million, beating the Zacks Consensus Estimate of $137 million, buoyed by double-digit sales growth from the clinical diagnostics and blood screening product businesses. Clinical diagnostic revenues grew 10%, fueled by higher adoption of APTIMA Combo 2 assay and Prodesse products. Blood screening product sales cruised 22% year over year to $55.7 million. Growth was supported by higher shipment of Procleix Ultrio and West Nile virus assays, as well as favorable currency ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/07/31/gpro-gen-probes-earnings-report-leaps-ahead-of-forecast/45488/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(GPRO) Gen-Probe Invests $50 Million in Pacific Biosciences</title>
		<link>http://www.stockbloghub.com/2010/07/05/gpro-gen-probe-invests-50-million-in-pacific-biosciences/40813</link>
		<comments>http://www.stockbloghub.com/2010/07/05/gpro-gen-probe-invests-50-million-in-pacific-biosciences/40813#comments</comments>
		<pubDate>Mon, 05 Jul 2010 16:14:37 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Research Services]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[Abbott Laboratories]]></category>
		<category><![CDATA[ABT]]></category>
		<category><![CDATA[BDX]]></category>
		<category><![CDATA[Becton Dickinson Company]]></category>
		<category><![CDATA[Gen-Probe Inc.]]></category>
		<category><![CDATA[GPRO]]></category>
		<category><![CDATA[NAT]]></category>
		<category><![CDATA[Nordic American Tanker Shipping Limited]]></category>
		<category><![CDATA[SMRT]]></category>
		<category><![CDATA[Stein Mart Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=40813</guid>
		<description><![CDATA[Diagnostic product maker Gen-Probe Inc (GPRO) has made a $50 million strategic investment in privately-held DNA sequencing firm Pacific Biosciences (PacBio). The companies will collaborate on developing products based on their proprietary technologies. Per the deal, the companies will combine their efforts to develop new clinical diagnostic systems, leveraging PacBio&#8217;s Single Molecule Real Time (SMRT) DNA sequencing technology platform and Gen-Probe&#8217;s diagnostic expertise. They will initially collaborate for up to 30 months with the goal of building a long-term relationship and improving diagnostic capabilities. Moreover, the companies will buy each other&#8217;s products on preferred terms of trade. California-based Gen-Probe has been a pioneer in the commercial and scientific development of nucleic acid testing (NAT) for the diagnosis of infectious diseases. The company sells its products in the clinical diagnostic as well ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/07/05/gpro-gen-probe-invests-50-million-in-pacific-biosciences/40813/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(NAT) Nordic American Tanker – Income and More</title>
		<link>http://www.stockbloghub.com/2009/07/02/nat-nordic-american-tanker-%e2%80%93-income-and-more/9361</link>
		<comments>http://www.stockbloghub.com/2009/07/02/nat-nordic-american-tanker-%e2%80%93-income-and-more/9361#comments</comments>
		<pubDate>Fri, 03 Jul 2009 03:48:31 +0000</pubDate>
		<dc:creator>InvestmentU</dc:creator>
				<category><![CDATA[Services]]></category>
		<category><![CDATA[Shipping]]></category>
		<category><![CDATA[NAT]]></category>
		<category><![CDATA[Nordic American Tanker Shippin]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=9361</guid>
		<description><![CDATA[Tony Daltorio, The Investment U Research Team One sector that is extremely sensitive to global economic activity is the international shipping industry. As the financial crisis turned into a category 5 hurricane last year, it blew the entire global economy off course –and along with it, the shipping industry. The sudden drying up of credit, finance institutions and collapsing trade volumes led to a sharp drop in shipping rates. Fast forward to today, and we’re now seeing ships being backed-up in Chinese and Australian ports: demand is rising. If these are indeed signs of a bottom, then we need to look for companies positioned correctly in the right shipping sector. And this is important, because each sector in the shipping industry – container, dry bulk, and oil – is fundamentally ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/07/02/nat-nordic-american-tanker-%e2%80%93-income-and-more/9361/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(FRO) Baltic Dry Index Floats Shippers</title>
		<link>http://www.stockbloghub.com/2008/12/17/fro-baltic-dry-index-floats-shippers/1753</link>
		<comments>http://www.stockbloghub.com/2008/12/17/fro-baltic-dry-index-floats-shippers/1753#comments</comments>
		<pubDate>Wed, 17 Dec 2008 18:03:30 +0000</pubDate>
		<dc:creator>InvestmentU</dc:creator>
				<category><![CDATA[Services]]></category>
		<category><![CDATA[Shipping]]></category>
		<category><![CDATA[FRO]]></category>
		<category><![CDATA[Frontline Ltd.]]></category>
		<category><![CDATA[KEX]]></category>
		<category><![CDATA[Kirby Corp.]]></category>
		<category><![CDATA[NAT]]></category>
		<category><![CDATA[Nordic American Tanker Shippin]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/2008/12/17/fro-baltic-dry-index-floats-shippers/1753</guid>
		<description><![CDATA[Baltic Dry Index Floats Shippers The Baltic Dry Index (BDI) is up over 10% to 711 in the past few weeks. It doesn&#8217;t mean much, considering it&#8217;s down over 93% for the year. In fact, if you consider this move in terms of this summer&#8217;s price high of 11,793 &#8211; it&#8217;s moved barely half a percent. But that doesn&#8217;t mean you shouldn&#8217;t be keeping an eye on the BDI. The BDI is the price used to determine global shipping rates and prices. Like blood pressure does for humans, BDI measures the flow of goods for the economies of the world. And just like us, excessively low or high readings are bad. Because it isn&#8217;t traded, the BDI cannot be moved artificially. It&#8217;s one of the best ways to judge the ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2008/12/17/fro-baltic-dry-index-floats-shippers/1753/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

